Re: The Clinicaltrail.gov site says July.

New Post Public Reply Private Reply Replies (1) Message Board
BruceLake DigitalTradz #8757
714
Re: The Clinicaltrail.gov site says July.

https://clinicaltrials.gov/ct2/show/NCT029767...amp;rank=1

This is incorrect. It created confusion for me and many others. Below is a series of back and forth emails with the company back in March. I gather that the one and only study that was meant to be done was the one done in Israel.


From: Me
To: alon.sinai@owcpharma.com
Sent: Thursday, March 09, 2017 1:13 PM
Subject: NCT02976779, OWC-PSO-01, A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Hello Mr. Sinai,

This study was to have begun last month. Could you please shed some light on its current status and why it has not begun yet?

Thank you in advance for your response.

Best regards
From: Me To:OWCP Cc: Alon Sinai ; Jeff Smurlick
Sent: Saturday, March 11, 2017 9:44 PM

Hello Amir,

I sent the email below to Alon Sinai a few days ago but I still have not received a reply. Perhaps the email did not reach him. I just wanted to know the status of this particular study and why it has still not begun.

https://clinicaltrials.gov/ct2/show/results/NCT02976779

Please reply asap. I'm also not able to find any reference online to the current clinical trials other than from OWCP's website. Just wondering where in Israel it is being conducted and at which facility.
The following site makes reference only to a March 2015 study but it was not with regards to the psoriasis cream.

https://www.centerwatch.com/search/?q=%22ONE%20WORLD%22

Thank you
Original Message
From: OWCP To: Me Cc: Alon Sinai ; Jeff Smurlick Sent: Saturday, March 11, 2017 10:54 PM
Subject: Re: NCT02976779, OWC-PSO-01, A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Hi
If I can read Your email properly than it seems to me you are asking for inside information , which of course , cannot be disclosed .
Please clarify

נשלח מה-iPhone שלי ב-12 במרץ 2017, בשעה 4:15 כתב/ה:‬ From: Me To:OWCP Cc: Alon Sinai ; Jeff Smurlick Sent: Saturday, March 12, 2017 12:32 AM Subject: Re: NCT02976779, OWC-PSO-01, A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Hello,
Not at all. I am not asking for insider information and I hope that we are clear about this.

Online I came across this study:
https://clinicaltrials.gov/ct2/show/results/NCT02976779

Am I correct to assume that this is a different study than the one currently being conducted? My question was and still is: Considering the study was to have begun in February and it was expected to be completed in July 2017, however on this site it states: "this study is not yet open for participant recruitment", so why has it not begun yet and what is it's current status?

Please clarify.

Thank you
Original Message
From: OWCP To: Me Cc: Alon Sinai ; Jeff Smurlick Sent: Sunday, March 12, 2017 12:21 PM Subject: Re: NCT02976779, OWC-PSO-01, A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Hi . First , thanks for the support Second , Just to be accurate : The company did not announce the start of the study on February . We announced that we received IRB approval to conduct the study.
The link : It is a federal link and might not be up to date.
After we received the approval , together with the hospital we recruited all the patients which mean the study is not open for free volunteers and , I guess , this what the link means.
‫ב-12 במרץ 2017, בשעה 6:32, ‏‏> כתב/ה:‬
S
From: Me To:OWCP Cc: Alon Sinai ; Jeff Smurlick Sent: Sunday, March 12, 2017 12:37 PM Subject: Re: NCT02976779, OWC-PSO-01, A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Thank you for the clarification, it is very much appreciated. What you state makes sense on all accounts.
Regards

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 3

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 3

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 3

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 5

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 3

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading

Top 5 Most Recently Viewed Articles

Aquí: Empowering Latino Voices with New Fellowship Program

Updated Category News Views 261

Aquí: The Accountability Movement launched its second class of Latino Speakers Bureau fellows back in 2024, marking a significant stride toward improving Latino representation in the media. With Latinos only making up 12% of the media workforce despite being a hefty part of the U. S. population, this initiative aimed to shake things up. It wasn't just about adding...

Continue Reading
Gilat Satellite Networks Announces Q2 2025 Financial Results

Updated Category News Views 159

Gilat Satellite Networks Set to Reveal Q2 2025 Results Gilat Satellite Networks Ltd. (NASDAQ: GILT), a prominent figure in satellite networking technology, has announced its schedule for releasing the financial results of its second quarter of 2025. This event aims to provide shareholders and the market with insights into the company’s performance and strategic...

Continue Reading
ANOS Capital Welcomes Five Seasoned Traders to Enhance Team

Updated Category News Views 34

ANOS Capital Expands Its Trading Team ANOS Capital, a prominent institutional brokerage firm, is thrilled to announce the addition of five senior equity sales trading professionals to its growing team. These strategic hires highlight the firm's commitment to improving its trading capabilities and delivering exceptional service to clients. New Hires from B. Riley Financial...

Continue Reading
Republic Services Achieves Prestigious Ethical Recognition for 2025

Updated Category News Views 142

Republic Services Honored for Ethical Business Practices Republic Services, Inc. (NYSE: RSG) has once again been recognized for its unwavering commitment to ethical business practices, earning the esteemed World's Most Ethical Companies designation for the seventh consecutive year. This recognition, awarded by Ethisphere, a prominent authority in promoting ethical...

Continue Reading
Innovative Nanoparticle Vaccine Offers Hope Against H5N1 Spread

Updated Category News Views 338

Revolutionary Vaccine Technology to Combat H5N1 Amid the alarming spread of the H5N1 avian influenza across various species, a groundbreaking vaccine developed by a University of Buffalo spin-off, POP Biotechnologies, is showing remarkable promise. Recent preclinical trials have reported that this nanoparticle vaccine is capable of providing complete protection against...

Continue Reading